Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorUniversity of Lausanne Hospitals

About this trial

The first study proposed is a small (n= 10 to 12 maximum) open feasibility trial of CAVEAT which is a 16-session manualized brief psychotherapy prototcol that is designed to help mothers of infants and young children, whereby the mothers have been exposed to interpersonal violence (i.e. childhood maltreatment and family violence, intimate and non-intimate partner violence, interpersonal combat and or other forms of terrorism or political violence including physical and sexual assault) and who have developed related post-traumatic stress. The treatment uses an integration and extension of evidence-based techniques: Modified Interaction Guidance, Prolonged Exposure Therapy for PTSD, Child-Parent Psychotherapy, and Minding the Baby, in order to help mothers with post-traumatic dysregulation and difficulty in their maintaining sensitivity during challenging parent-child interactions (i.e. when mothers are confronted with child helpless states, emotion dysregulation, negative affect and child aggression). Outcome measures will initially include: maternal attributions towards her child (i.e. perception of child's personality), maternal-child behavior, and maternal-child symptoms of attachment disturbance and PTSD. This feasibility study is meant to perfect the manual and to prepare for an initial open trial with a larger clinical sample including analysis of pre- and post-intervention measures before further randomized control study can be done.

Eligibility criteria

Qualifiers

Biological mothers of infants and young children ages 12-54 months

Mothers and infants have lived together most of the child's life from the time of birth

Disqualifiers

Actively psychotic or substance-abusing mothers;

Mothers and/or children who are physically or mentally handicapped so as to prevent adequate participation in required research tasks

Trial design

Treatments tested in this trial

  • CAVEAT

Treatment groups

24 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Lausanne Hospitals

Lead sponsor

International Psychoanalytical Association

Collaborator